相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial
Andrew H. Wei et al.
BLOOD (2020)
Regimen-intensity per count-recovery and hospitalization index: A new tool to assign regimen intensity for AML
Mohamed L. Sorror et al.
CANCER MEDICINE (2020)
Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia
C. D. DiNardo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Quality of life and mood of older patients with acute myeloid leukemia (AML) receiving intensive and non-intensive chemotherapy
Areej El-Jawahri et al.
LEUKEMIA (2019)
Improved survival rates of AML patients following admission to the intensive care unit
Priska Fassbind et al.
LEUKEMIA & LYMPHOMA (2019)
Revised Acute Myeloid Leukemia Composite Model Using the 2017 European Leukemia Net Risk Classification
Mohamed L. Sorror et al.
JAMA ONCOLOGY (2019)
An Important Gap in Informed Consent Documents for Oncology Clinical Trials: Lack of Quantitative Details About Expected Treatment Outcomes
Charles A. Schiffer
JAMA ONCOLOGY (2019)
Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD
Richard F. Schlenk et al.
BLOOD (2019)
Randomized comparison of low dose cytarabine with or without glasdegib in patients with newly diagnosed acute myeloid leukemia or high-risk myelodysplastic syndrome
Jorge E. Cortes et al.
LEUKEMIA (2019)
Physician uncertainty aversion impacts medical decision making for older patients with acute myeloid leukemia: results of a national survey
Pierre Bories et al.
HAEMATOLOGICA (2018)
Physician uncertainty aversion impacts medical decision making for older patients with acute myeloid leukemia: results of a national survey
Pierre Bories et al.
HAEMATOLOGICA (2018)
Incorporating Physical Function and Cognition Into Mortality Risk Assessment for Acute Myeloid Leukemia Reply
Mohamed L. Sorror et al.
JAMA ONCOLOGY (2018)
Incorporating Physical Function and Cognition Into Mortality Risk Assessment for Acute Myeloid Leukemia
Kah Poh Loh et al.
JAMA ONCOLOGY (2018)
Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology Summary
Supriya G. Mohile et al.
JOURNAL OF ONCOLOGY PRACTICE (2018)
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
Hartmut Doehner et al.
BLOOD (2017)
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation
R. M. Stone et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Development and Validation of a Novel Acute Myeloid Leukemia-Composite Model to Estimate Risks of Mortality
Mohamed L. Sorror et al.
JAMA ONCOLOGY (2017)
Statewide Geographic Variation in Outcomes for Adults With Acute Myeloid Leukemia in North Carolina
Ashley T. Freeman et al.
CANCER (2016)
Acute Myeloid Leukemia - Many Diseases, Many Treatments
Elihu Estey
NEW ENGLAND JOURNAL OF MEDICINE (2016)
TP53 and Decitabine in Acute Myeloid Leukemia and Myelodysplastic Syndromes
J. S. Welch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Big data analysis of treatment patterns and outcomes among elderly acute myeloid leukemia patients in the United States
Bruno C. Medeiros et al.
ANNALS OF HEMATOLOGY (2015)
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
Herve Dombret et al.
BLOOD (2015)
Primary antifungal prophylaxis during curative-intent therapy for acute myeloid leukemia
Anna B. Halpern et al.
BLOOD (2015)
Epidemiology and Clinical Significance of Secondary and Therapy-Related Acute Myeloid Leukemia: A National Population-Based Cohort Study
Lene Sofie Granfeldt Ostgard et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations
L. Decoster et al.
ANNALS OF ONCOLOGY (2015)
Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials
Robert K. Hills et al.
LANCET ONCOLOGY (2014)
Declining rates of treatment-related mortality in patients with newly diagnosed AML given 'intense' induction regimens: a report from SWOG and MD Anderson
M. Othus et al.
LEUKEMIA (2014)
Geriatric assessment predicts survival for older adults receiving induction chemotherapy for acute myelogenous leukemia
Heidi D. Klepin et al.
BLOOD (2013)
Outcome of older patients with acute myeloid leukemia: An Analysis of SEER Data Over 3 Decades
Mya S. Thein et al.
CANCER (2013)
Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome
Barbara Deschler et al.
HAEMATOLOGICA (2013)
Geriatric assessment in older patients with acute myeloid leukemia: A retrospective study of associated treatment and outcomes
Alexander E. Sherman et al.
LEUKEMIA RESEARCH (2013)
Acute myeloid leukemia in the real world: why population-based registries are needed
Gunnar Juliusson et al.
BLOOD (2012)
Pretreatment risk factors and importance of comorbidity for overall survival, complete remission, and early death in patients with acute myeloid leukemia
Irena Djunic et al.
HEMATOLOGY (2012)
Multicenter, Randomized, Open-Label, Phase III Trial of Decitabine Versus Patient Choice, With Physician Advice, of Either Supportive Care or Low-Dose Cytarabine for the Treatment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia
Hagop M. Kantarjian et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Preparative Regimens and Ageism
Frederick R. Appelbaum
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2011)
Most 70-to 79-year-old patients with acute myeloid leukemia do benefit from intensive treatment
Gunnar Juliusson
BLOOD (2011)
Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
Pierre Fenaux et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Multicenter, Phase II Study of Decitabine for the First-Line Treatment of Older Patients With Acute Myeloid Leukemia
Amanda F. Cashen et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Effect of Complete Remission and Responses Less Than Complete Remission on Survival in Acute Myeloid Leukemia: A Combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M. D. Anderson Cancer Center Study
Roland B. Walter et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
Gunnar Juliusson et al.
BLOOD (2009)
High-Dose Daunorubicin in Older Patients with Acute Myeloid Leukemia
Bob Lowenberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Hematopoietic cell transplantation-comorbidity index and Karnofsky performance status are independent predictors of morbidity and mortality after allogeneic nonmyeloablative hematopoietic cell transplantation
Mohamed Sorror et al.
CANCER (2008)
Attitude towards remission induction for elderly patients with acute myeloid leukemia influences survival
G Juliusson et al.
LEUKEMIA (2006)
Use of comprehensive geriatric assessment in older cancer patients: Recommendations from the task force on CGA of the International Society of Geriatric Oncology (SIOG)
M Extermann et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)
Measuring comorbidity in older cancer patients
M Extermann
EUROPEAN JOURNAL OF CANCER (2000)
Marginal structural models and causal inference in epidemiology
JM Robins et al.
EPIDEMIOLOGY (2000)
分享论文
